Group 1 - The core point of the article is that Kintor Pharmaceutical Co., Ltd. (02171) has announced an updated share repurchase plan, which will allow the company to buy back up to 25.461 million shares over a period of 50 trading days starting from November 13, 2025 [1] - The updated share repurchase plan represents approximately 5% of the total issued shares as of the date of the authorization in 2025 [1] - Following the announcement, Kintor's stock price increased by over 4%, reaching HKD 18.3 with a trading volume of HKD 12.33 million [1] Group 2 - The board of directors has been informed that Eucure Biopharma Co., Ltd. and its concert parties have cumulatively purchased 100,000 shares between November 6 and November 10, 2025 [1] - After this acquisition, Eucure and its concert parties hold a total of 218 million shares, which accounts for approximately 37.92% of the total issued shares as of the announcement date, excluding treasury shares [1]
港股异动 | 科济药业-B(02171)涨超4% 公司购回股份及主要股东增持股份